Abstract
Telomerase is a specialized ribonucleoprotein polymerase that directs the synthesis of telomere repeats at chromosome ends. Accumulating evidence has indicated that telomerase is stringently repressed in normal human somatic tissues but reactivated in cancers and immortal cells, suggesting that reactivation of telomerase plays an important role in carcinogenesis. In this study, the status of telomerase activity in diseased human nasopharyngeal lesions was determined by the telomeric repeat amplification protocol (TRAP). Fifty-four patients participated including 17 inflammation or hyperplasia, eight with squamous metaplasia, and 29 with different stages of carcinomas. Telomerase activity was detected in 1 of 17 (5.9%) inflammatory or lymphoid hyperplastic tissues, 3 of 8 (37.5%) squamous metaplastic, and 25 of 29 (86.2%) carcinoma tissues. The differences in telomerase expression in these groups is statistically significant (P< 0.001). Levels of telomerase activity correlated with tumour stage (P = 0.024). These results suggest that telomerase reactivation plays a role in the carcinogenesis of nasopharyngeal cancer. Since telomerase activity is found in the majority of nasopharyngeal cancers and a subset of metaplasia, this enzyme may be served as a reference to monitoring the status of abnormal nasopharyngeal tissues. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Blackburn EH (1992) Telomerase. Annu Rev Biochem 61: 113–129
Califano J, Ahrendt SA, Meininger G, Westra WH, Koch WM and Sidransky D (1996) Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 56: 5720–5722
Campisi J (1997) The biology of replicative senescence. Eur J Cancer 33: 703–309
Chang JT, See LC, Tang SG, Lee SP, Wang CC and Hong JH (1996) The role of brachytherapy in early-stage nasopharyngeal carcinoma. Int J Radiation Oncol Biol Phys 36: 1019–1024
Cheng A-J, Liao S-K, Chow S-E, Chen J-K and Wang T-CV (1997) Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture. Biochem Biophys Res Commun 237: 438–444
Cheng A-J, Lin J-D, Chang T and Wang T-CV (1998) Telomerase activity in benign and malignant human thyroid tissues. Br J Cancer 77: 2177–2180
Cheng A-J, Tang R, Wang J-Y, Chang JT and Wang T-C (1999) Polymerase chain reaction-based enzyme immunoassay for quantitation of telomerase activity: application to colorectal cancers. Jpn J Cancer Res 90: 280–285
Cheng RYS, Yuen PW, Nicholls JM, Zheng Z, Wei W, Sham JST, Yang XH, Cao L, Huang DP and Tsao SW (1998) Telomerase activation in nasopharyngeal carcinomas. Br J Cancer 77: 456–460
Choi PHK, Suen MWN, Path MRC, Huang DP, Lo KW and Lee J (1993) Nasopharyngeal carcinoma: genetic changes, Epstein-Barr virus infection, or both. Cancer 72: 2873–2878
Cuthbert AP, Bond J, Trott DA, Gill S, Broni J, Marriott A, Khoudoli G, Parkinson EK, Cooper CS and Newbold RF (1999) Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst 91: 37–45
Fandi A and Cvitkovic E (1994) Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol 21: 376–381
Fandi A and Cvitkovic E (1995) Biology and treatment of nasopharyngeal cancer. Curr Opin Oncol 7: 255–263
Feng BC and Liu KL (1989) A morphological study of stromal microvasculature of nasopharyngeal precancerous lesions. Clin Med J (Engl) 104: 422–424
Hedinger C, Williams ED and Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63: 908–911
Herle-Bachor C and Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476–6481
Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind Ch, (eds) (1997) UICC TNM Atlas Springer: New York
Hiyama E, Yoyama T, Tatsumoto N, Hiyama K, Imamura Y and Matsuura Y (1995) Telomerase activity in gastric cancer. Cancer Res 55: 3258–3262
Hiyama E, Kodama T, Shinbara K, Iwao Y, Itoh M, Hiyama K, Shay JW, Matsuura Y and Yokoyama T (1997) Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57: 326–331
Horikawa I, Oshimura M and Barrett JC (1998) Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog 22: 65–72
Huang DP, Lo KW, Choi PHK, Ng AYT, Tsao SY, Yiu GKC and Lee JCK (1991) Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet Cytogenet 54: 91–99
Huang DP, Lo KW, van Hasselt CA, Woo JKS, Choi PHK, Leung SF, Cheung ST, Caims P, Sidransky D and Lee JCK (1994) A region of homozygous deletion on chromosome 9p21–22 in primary nasopharyngeal carcinoma. Cancer Res 54: 4003–4006
Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD and Chiu CP (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21: 111–114
Kameshima H, Yagihashi A, Yajima T and Watanabe N (1999) Helicobacter pylori infection induces telomerase activity in premalignant lesions. Am J Gastroenterol 94: 547
Kieserman SP and Stern J (1995) Malignant transformation of hasopharyngeal lymphoid hyperplasia. Otolaryngol Head Neck Surg 113: 474–476
Kristensen S, Tverteras K, Friedmann I and Thomsen P (1989) Nasopharyngeal Warthin’s tumor: a metaplastic lesion. J Laryngol Otol 103: 616–619
Ku W-C, Cheng A-J and Wang T-CV (1997) Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochem Biophys Res Commun 241: 730–736
Kyo S, Takakura M, Kohama T and Inoue M (1997) Telomerase activity in human endometrium. Cancer Res 57: 610–614
Liebowitz D (1994) Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol 21: 376–381
Lu S, Day NE, Degos L, Lepage V, Wang P-C, Chan S-H, Simons M, McKnight B, Easton D, Zeng Y and deThe G (1990) Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 346: 470–471
Mao L, El-Naggar AK, Fan YH, Lee JS, Lippman SM, Kayser S, Lotan R and Hong WK (1996) Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res 56: 5600–5604
Mehle C, Lindblom A, Ljungberg B, Stenling R and Roos G (1998) Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. Int J Oncol 13: 289–295
Morales CP, Holt S, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE and Shay JW (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21: 115–118
Morin GB (1997) The implications of telomerase biochemistry for human disease. Eur J Cancer 33: 750–560
Mutirangura A, Supiyaphun P, Trirekapaii S, Sriuranpong V, Sakuntabhai A, Yenrudi S and Voravud N (1996) Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res 6: 3530–3533
Ramirez RD, Wright WE, Shay JW and Taylor RS (1997) Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108: 113–117
Shay JW and Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787–791
Sugino T, Yoshida K, Bolodeokul J, Tahara H, Buley I, Manek S, Wells C, Goodison S, Ide T, Suzuki T, Tahara E and Tarin D (1996) Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer 69: 301–306
Tahara H, Nakanislii T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G and Ide T (1995) Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734–2736
Tanaka H, Shimizu M, Horikawa I, Kugoh H, Yokota J, Barrett JC and Oshimura M (1998) Evidence for a putative telomerase repressor gene in the 3p14.2–p21.1 region. Genes Chromosomes Cancer 23: 123–133
Tang R, Cheng AJ, Wang JY and Wang TC (1998) Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis. Cancer Res 58: 4052–4054
Wright WE, Piatyszek MA, Rainey WE, Byrd W and Shay JW (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173–179
Yeldandi AV, Kaufman DG and Reddy JK (1996) Cell injury and cellular adaptation. In: Anderson’s Pathology Damjanov I Linder J (eds), pp. 357–386, Mosby-Year Book, Inc: New York
Yu MC (1991) Nasopharyngeal carcinoma: epidemiology and dietary factors Lyon, IARC Scientific Publication: France
Zong YS and Zheng WJ (1989) A morphologic and follow-up study on the nasopharyngeal lymphoid hyperplasia and its relation to the cancer. Clin Med J (Engl) 102: 625–629
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Chang, JC., Liao, CT., Jung, SM. et al. Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues. Br J Cancer 82, 1946–1951 (2000). https://doi.org/10.1054/bjoc.2000.1194
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1194
Keywords
This article is cited by
-
Epstein–Barr virus: more than 50 years old and still providing surprises
Nature Reviews Cancer (2016)
-
Locally advanced nasopharyngeal cancer
Current Treatment Options in Oncology (2001)